US Patent 11554156 Pharmaceutical formulations of C1 esterase inhibitor
Patent 11554156 was granted and assigned to CSL Behring on January, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115541560
Date of Patent
January 17, 2023
0Patent Application Number
169329190
Date Filed
July 20, 2020
0Patent Citations
Patent Primary Examiner
Edits on 27 Mar, 2023
Golden AI
Infobox
Edits on 18 Jan, 2023
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+330 characters)
US Patent 11554156 Pharmaceutical formulations of C1 esterase inhibitor
Article
The present invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (C1-INH), exhibiting a higher stability for prolonged storage and a reduced formation of aggregates of said esterase inhibitor (C1-INH) upon storage for ameliorated use in treating or preventing disorders related to kinin formation.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115541560
Date of Patent
January 17, 2023
0Patent Application Number
169329190
Date Filed
July 20, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11554156 Pharmaceutical formulations of C1 esterase inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
